跳至主要内容
临床试验/JPRN-UMIN000039967
JPRN-UMIN000039967已完成未知

Examination on the differences of the symptoms which should be given priority to treatment from the perspective of major depressive disorder patients vs their physicians - Examination on the differences of the symptoms which should be given priority to treatment from the perspective of major depressive disorder patients vs their physicians

Takeda Pharmaceutical Company Limited.0 个研究点目标入组 828 人开始时间: 2020年3月27日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
828

研究概览

简要总结

Of the 2618 patients, 828 were assigned to 326 physicians. Fewer physicians than patients reported physical symptoms in the mild stage and cognitive symptoms in the severe and mild stages. Social function was deemed to be lower by physicians than by patients across all stages. Regarding treatment expectations, more physicians than patients reported "return to a normal life" in the mild and remission stages, and more patients than physicians reported "reduction of side effects" in the severe and mild stages.

研究设计

研究类型
Others,meta-analysis etc

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • [Survey in patients] 1) Physicians who are employed by a pharmaceutical company or marketing agency. 2) Patients who show 9 or less score of PHQ-9 survey in their most severe MDD symptoms in the past. [Survey in physicians] 1)Physicians themselves or their relatives are employed by a pharmaceutical company or marketing agency.

研究者

相似试验